Differences

This shows you the differences between two versions of the page.

--- canadian_immunization_research_network [2022/03/20 04:16]
liam [Canadian Immunization Research Network]
+++ canadian_immunization_research_network [2023/09/08 20:42] (current)
liam
@@ Line 3: / Line 3: @@
 {{ :92d84b60eaf907f14c7e544b460cc7fd770a5a25.png?200|}}
-CIRN is a self-described "network of networks" that provides data to inform public health decision-making about immunization programs. CIRN is involved in clinical research, surveillance and epidemiological research, and public health program evaluation. The group's focus is on late-stage vaccine evaluation of program implementation.((//About Us.// (2013, January 30). CIRN | Canadian Immunization Research Network. https://archive.ph/JOVmZ))
+The **Canadian Immunization Research Network (CIRN)** is a self-described "network of networks" that provides data to inform public health decision-making about immunization programs. CIRN is involved in clinical research, surveillance and epidemiological research, and public health program evaluation. The group's focus is on late-stage vaccine evaluation of program implementation.((//About Us.// (2013, January 30). CIRN | Canadian Immunization Research Network. https://archive.ph/JOVmZ))
 The program operated as the PHAC/CIHR Influenza Research Network (PCIRN) from 2009-2014 then relaunched as CIRN from June 2014 – May 2017 with a three-year grant of $6.6 million from PHAC and CIHR. A directed CIRN renewal grant application was submitted in February 2017. In April 2017, the network was notified that it is fully funded for $10,083,334 over the next 55 months, 2017-2022.
 ===== Funding =====
-CIRN is partnered with and funded by [[pharmaceutical_companies:pfizer|Pfizer]], [[GSK|GlaxoSmithKline]], [[Sanofi]], [[Novartis]], and [[VBI Vaccines]], as well as the [[Canadian Institutes of Health Research]] (CIHR) and the [[Public Health Agency of Canada]] (PHAC).((Canadian Immunization Research Network (CIRN). (2018, February 26). //Partners.// Retrieved November 25, 2021, from https://archive.ph/durb0)) ((Canadian Immunization Research Network (CIRN). //CIRN Annual Report 2019–2020.// Retrieved December 22, 2021, from https://www.campfire.wiki/lib/exe/fetch.php?media=ar.2019-20.final_.pdf)) ((//Annual Report 2015.// Canadian Immunization Research Network. Retrieved December 22, 2021, from https://cirnetwork.ca/annual-reports/2015/mobile/index.html#p=24)) ((//Annual Report 2014.// Canadian Immunization Research Network. Retrieved December 22, 2021, from https://cirnetwork.ca/annual-reports/2014/mobile/index.html#p=1)) ((//2013 Annual Report.// PHAC/CIHR Influenza Research Network. Retrieved December 22, 2021, from https://www.campfire.wiki/lib/exe/fetch.php?media=pcirn-annual-reportfinal-2013.pdf))
+CIRN is partnered with and funded by [[pharmaceutical_companies:pfizer|Pfizer]], [[GSK|GlaxoSmithKline]], [[Sanofi]], [[Novartis]], and [[VBI Vaccines]], as well as the [[Canadian Institutes of Health Research]] (CIHR) and the [[Public Health Agency of Canada]] (PHAC).((Canadian Immunization Research Network (CIRN). (2018, February 26). //Partners.// Retrieved November 25, 2021, from https://archive.ph/durb0)) ((Canadian Immunization Research Network (CIRN). //CIRN Annual Report 2019–2020.// Retrieved March 28, 2023, from https://web.archive.org/web/20230328075033/https://cirnetwork.ca/wp-content/uploads/2021/08/AR.2019-20.Final_.pdf)) ((//Annual Report 2015.// Canadian Immunization Research Network. Retrieved December 22, 2021, from https://cirnetwork.ca/annual-reports/2015/mobile/index.html#p=24)) ((//Annual Report 2014.// Canadian Immunization Research Network. Retrieved December 22, 2021, from https://cirnetwork.ca/annual-reports/2014/mobile/index.html#p=1)) ((//2013 Annual Report.// PHAC/CIHR Influenza Research Network. Retrieved December 22, 2021, from https://www.campfire.wiki/lib/exe/fetch.php?media=pcirn-annual-reportfinal-2013.pdf))
 ===== Studies =====
@@ Line 18: / Line 18: @@
 ==== MOSAIC ====
-COVID-19 injection programs started in Canada in December 2020 with products from [[pharmaceutical_companies:pfizer|Pfizer]], [[Moderna]] and [[AstraZeneca]] becoming available over the winter and into spring of 2021. In Canada, a strategy to deliver as many first doses as possible resulted in mixed brands (giving a different second COVID-19 dose to the first dose) and schedules (length of time between doses) being used in many parts of the country. This was in spite of no prior testing for safety or efficacy of mixing products.
+[[covid-19_vaccines:COVID-19 injection]] programs started in [[Canada]] in December 2020 with products from [[pharmaceutical_companies:Pfizer]], [[pharmaceutical_companies:Moderna]] and [[pharmaceutical_companies:AstraZeneca]] becoming available over the winter and into spring of [[covid-19_pandemic:timeline|2021]]. In Canada, a strategy to deliver as many first doses as possible resulted in mixed brands (giving a different second COVID-19 dose to the first dose) and schedules (length of time between doses) being used in many parts of the country. This was in spite of no prior testing for safety or efficacy of mixing products.
 === MOSAIC-1 ===
@@ Line 26: / Line 26: @@
 === MOSAIC-2 ===
-The second iteration of the study began in December 2021 to evaluate a third (3rd) dose of an authorized COVID-19 injection in adults. It is intended to evaluate the safety, tolerability, and immune response of a third dose of a COVID-19 product authorized in Canada (either the [[Pfizer-BioNTech]] or [[Moderna]] mRNA products) in people who had two doses of COVID-19 injections at least six months ago.
+The second iteration of the study began in December 2021 to evaluate a third (3rd) dose of an authorized COVID-19 injection in adults. It is intended to evaluate the safety, tolerability, and immune response of a third dose of a COVID-19 product authorized in Canada (either the [[pharmaceutical_companies:Pfizer]]-[[pharmaceutical_companies:BioNTech]] or [[pharmaceutical_companies:Moderna]] mRNA products) in people who had two doses of [[covid-19_vaccines|COVID-19 injections]] at least six months ago.
-The study is led by the Clinical Trials Network of the Canadian Immunization Network (CIRN) and funded by the [[COVID-19 Immunity Task Force]]. It is led by Dr. Joanne Langley and Dr. Manish Sadarangani.((//MOSAIC.//  CIRN | Canadian Immunization Research Network. Retrieved December 23, 2021, from https://archive.ph/mvQMN))
+The study is led by the Clinical Trials Network of the Canadian Immunization Network (CIRN) and funded by the [[COVID-19 Immunity Task Force]]. It is led by Dr. [[Joanne Langley]] and Dr. [[Manish Sadarangani]].((//MOSAIC.//  CIRN | Canadian Immunization Research Network. Retrieved December 23, 2021, from https://archive.ph/mvQMN))
 ===== Annual Reports =====
@@ Line 34: / Line 34: @@
 Annual reports for these organizations are a gold mine. More to be unearthed from within and added to this page.
-  * 2019-2020: https://www.campfire.wiki/lib/exe/fetch.php?media=ar.2019-20.final_.pdf
+  * 2019-2020: https://web.archive.org/web/20230328075033/https://cirnetwork.ca/wp-content/uploads/2021/08/AR.2019-20.Final_.pdf
   * 2018-2019: https://www.campfire.wiki/lib/exe/fetch.php?media=cirn-annual-report-2019-jan4.pdf
   * 2017-2018: https://www.campfire.wiki/lib/exe/fetch.php?media=cirn_annual_report_2017-18.pdf
@@ Line 41: / Line 41: @@
   * 2014: https://cirnetwork.ca/annual-reports/2014/mobile/index.html
   * 2013: https://www.campfire.wiki/lib/exe/fetch.php?media=pcirn-annual-reportfinal-2013.pdf
+===== External links =====
+  * [[http://covidtruthinitiative.ca/en/Organizations/Nova-Scotia-Health-Authority/IWK-Health-Centre/Canadian-Center-for-Vaccinology/Canadian-Immunization-Research-Network|COVID Truth Initiative]]